Mali Barbi

Introduction Breast cancer (BCA) mortality has declined substantially over the last 40 years, in part due to the use of adjuvant systemic therapies to decrease the risk of recurrence, including adjuvant chemotherapy, endocrine therapy, and targeted anti- human epidermal growth factor receptor 2 (HER2) therapy. For adjuvant endocrine therapy and anti-HER2 therapy, predictive factors for therapeutic benefit include hormone receptor expression and HER2/neu overexpression, respectively.

Esha Sehanobish, PhD Mali Barbi Valerie Fong Meryl Kravitz Cynthia Matsumura Denise Tejera Mohammad Asad, PhD Denisa Ferastraoaru, MD Meaghan O'Neill Merhunisa Karagic Nadeem Akhbar Danielle Bottalico Viraj Patel Golda Hudes, MD PhD Mimi Kim Ruth Eisenberg Avindra Nath Bryan Smith Thomas Ow Elina Jerschow, MD FAAAAI DOI:https://doi.org/10.1016/j.jaci.2020.12.488 Anosmia and ageusia are associated with COVID-19 in addition to other symptoms.